Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (May 12, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16th. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast replay will be available approximately 48 hours after the live webcast.

      Press Contact:
      Linda Fedow
      (732) 524-6071

      Investor Contact:
      Raychel Kruper
      (732) 524-6164

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.